相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。C-C chemokine receptor type 5 (CCR5) utilization of transmitted and early founder human immunodeficiency virus type 1 envelopes and sensitivity to small-molecule CCR5 inhibitors
Qinxue Hu et al.
JOURNAL OF GENERAL VIROLOGY (2010)
Characterization of Emergent HIV Resistance in Treatment-Naive Subjects Enrolled in a Vicriviroc Phase 2 Trial
Paul McNicholas et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
SDF-1/CXCL12 Production by Mature Dendritic Cells Inhibits the Propagation of X4-Tropic HIV-1 Isolates at the Dendritic Cell-T-Cell Infectious Synapse
Nuria Gonzalez et al.
JOURNAL OF VIROLOGY (2010)
Binding Thermodynamics of the N-Terminal Peptide of the CCR5 Coreceptor to HIV-1 Envelope Glycoprotein gp120
Evan T. Brower et al.
BIOCHEMISTRY (2009)
HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1
Appakkudal R. Anand et al.
BLOOD (2009)
Maraviroc: perspectives for use in antiretroviral-naive HIV-1-infected patients
Linos Vandekerckhove et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the Protean Effects of Selective Antagonists
Denis Sohy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Relative Activity of Function Sparing HIV-1 Entry Inhibitors on Viral Entry and CCR5 Internalization: Is Allosteric Functional Selectivity a Valuable Therapeutic Property?
Vanessa M. Muniz-Medina et al.
MOLECULAR PHARMACOLOGY (2009)
The structure and function of G-protein-coupled receptors
Daniel M. Rosenbaum et al.
NATURE (2009)
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Xiao Jie Yao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The apparent cooperativity of some GPCRs does not necessarily imply dimerization
Marc Chabre et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Quantifying the relationship between HIV-1 susceptibility to CCR5 antagonists and virus affinity for antagonist-occupied co-receptor
Peter J. Buontempo et al.
VIROLOGY (2009)
Inefficient entry of vicriviroc-resistant HIV-1 via the inhibitor-CCR5 complex at low cell surface CCR5 densities
Pavel Pugach et al.
VIROLOGY (2009)
Involvement of the second extracellular loop and transmembrane residues of CCR5 in inhibitor binding and HIV-1 fusion: Insights into the mechanism of allosteric inhibition
Kenji Maeda et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1
Alonso Heredia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular interactions of CCR5 with major classes of small-molecule anti-HIV CCR5 antagonists
Rama Kondru et al.
MOLECULAR PHARMACOLOGY (2008)
Functional selectivity through protean and biased agonism: Who steers the ship?
Terry Kenakin
MOLECULAR PHARMACOLOGY (2007)
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
Chih-chin Huang et al.
SCIENCE (2007)
Allosteric effects of antagonists on signalling by the chemokine receptor CCR5
Ben Haworth et al.
BIOCHEMICAL PHARMACOLOGY (2007)
HIV-1 clones resistant to a small molecule CCR5 inhibitor use the inhibitor-bound form of CCR5 for entry
Pavel Pugach et al.
VIROLOGY (2007)
Reduced maximal inhibition in phenotypic susceptibility assays indicates that viral strains resistant to the CCR5 antagonist maraviroc utilize inhibitor-bound receptor for entry
Mike Westby et al.
JOURNAL OF VIROLOGY (2007)
A new strategy based on recombinant viruses as a tool for assessing drug susceptibility of human immunodeficiency virus type 1
J. Garcia-Perez et al.
JOURNAL OF MEDICAL VIROLOGY (2007)
CD4 and CCR5 constitutively interact at the plasma membrane of living cells -: A confocal fluorescence resonance energy transfer-based approach
Gerald Gaibelet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Genetics of resistance to HIV infection: Role of co-receptors and co-receptor ligands
Fernando Arenzana-Seisdedos et al.
SEMINARS IN IMMUNOLOGY (2006)
An anti-CCR5 monoclonal antibody and small molecule CCR5 antagonists synergize by inhibiting different stages of human immunodeficiency virus type 1 entry
Diana Safarian et al.
VIROLOGY (2006)
Structural and molecular interactions of CCR5 inhibitors with CCR5
K Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Allosteric modulation of binding properties between units of chemokine receptor homo- and hetero-oligomers
JY Springael et al.
MOLECULAR PHARMACOLOGY (2006)
Molecular cloning and radioligand binding characterization of the chemokine receptor CCR5 from rhesus macaque and human
C Napier et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1
JM Strizki et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Ternary complex formation of human immunodeficiency virus type 1 Env, CD4, and chemokine receptor captured as an intermediate of membrane fusion
SR Mkrtchyan et al.
JOURNAL OF VIROLOGY (2005)
The HIV coreceptor switch: a population dynamical perspective
RR Regoes et al.
TRENDS IN MICROBIOLOGY (2005)
Mutation of the DRY motif reveals different structural requirements for the CC chemokine receptor 5-mediated signaling and receptor endocytosis
B Lagane et al.
MOLECULAR PHARMACOLOGY (2005)
Solubilization, stabilization, and purification of chemokine receptors using biosensor technology
I Navratilova et al.
ANALYTICAL BIOCHEMISTRY (2005)
The CCR5 receptor-based mechanism of action of 873140, a potent allosteric noncompetitive HIV entry inhibitor
C Watson et al.
MOLECULAR PHARMACOLOGY (2005)
Spirodiketopiperazine-based CCR5 inhibitor which preserves CC-Chemokine/CCR5 interactions and exerts potent activity against R5 human immunodeficiency virus type 1 in vitro
K Maeda et al.
JOURNAL OF VIROLOGY (2004)
Chemokine receptor CCR5: insights into structure, function, and regulation
M Oppermann
CELLULAR SIGNALLING (2004)
Realistic protein-protein association rates from a simple diffusional model neglecting long-range interactions, free energy barriers, and landscape ruggedness
M Schlosshauer et al.
PROTEIN SCIENCE (2004)
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entry
F Tsamis et al.
JOURNAL OF VIROLOGY (2003)
Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES
C Pastore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
G protein-dependent CCR5 signaling is not required for efficient infection of primary T lymphocytes and macrophages by R5 human immunodeficiency virus type I isolates
A Amara et al.
JOURNAL OF VIROLOGY (2003)
Activation of CCR5 by chemokines involves an aromatic cluster between transmembrane helices 2 and 3
C Govaerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies
C Blanpain et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
HIV-1 gp120 and chemokine activation of Pyk2 and mitogen-activated protein kinases in primary macrophages mediated by calcium-dependent, pertussis toxin-insensitive chemokine receptor signaling
M Del Corno et al.
BLOOD (2001)
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
JM Strizki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Human immunodeficiency virus type-1 and chemokines: beyond competition for common cellular receptors
TS Stantchev et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2001)
The TXP motif in the second transmembrane helix of CCR5 - A structural determinant of chemokine-induced activation
C Govaerts et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140
A Trkola et al.
JOURNAL OF VIROLOGY (2001)
Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate
I Staropoli et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Coreceptor competition for association with CD4 may change the susceptibility of human cells to infection with T-tropic and macrophagetropic isolates of human immunodeficiency virus type 1
S Lee et al.
JOURNAL OF VIROLOGY (2000)
A binding pocket for a small molecule inhibitor of HIV-1 entry within the transmembrane helices of CCR5
T Dragic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
